IDF President-Elect meets Dr. Jitendra Singh to boost indigenous biosimilar insulin production and diabetes biomanufacturing in India, focusing on affordability, supply security, and industry collaboration.
Industrial talks | 08/04/2026 | By News Bureau
Cipla USA Secures USFDA Approval for Generic Nintedanib to Treat Pulmonary Fibrosis
Cipla USA receives USFDA approval for generic Nintedanib capsules, expanding access to treatment for patients with idiopathic pulmonary fibrosis in the United States.
Industrial talks | 06/04/2026 | By News Bureau | 293
India Pharma 2026 to Spotlight Innovation-Driven Growth in Life Sciences
The Department of Pharmaceuticals (DoP), in collaboration with Federation of Indian Chambers of Commerce & Industry (FICCI) and Indian Pharmaceutical Alliance, will host the 9th edition of India Pharma 2026 on April 13–14, 2026, at Federation House, New Delhi.
Industrial talks | 06/04/2026 | By Darshana | 361
NICE Recommends Weekly Semaglutide Injection to Prevent Heart Attacks and Strokes
NICE advises use of semaglutide injections for patients with prior cardiovascular conditions and excess weight to lower risk of future serious events.
Industrial talks | 04/04/2026 | By News Bureau | 115
Novavax Appoints Robert Walker as EVP and Head of R&D
Novavax appoints Robert Walker as EVP and Head of R&D, bringing 30+ years of experience to advance its pipeline, Matrix adjuvant innovation and advancement of the company pipeline.
Industrial talks | 31/03/2026 | By News Bureau | 147
Royal Philips Tops EPO MedTech Patent Rankings, Reinforces Innovation Leadership
Royal Philips has secured the top position among medical technology companies in the European Patent Office’s (EPO) Technology Dashboard 2025, underscoring its continued leadership in health technology innovation.
Industrial talks | 26/03/2026 | By Darshana | 141
CDR-Life Hits First Milestone in Boehringer Ingelheim Autoimmune Deal
CDR-Life has achieved its first milestone in its partnership with Boehringer Ingelheim, advancing an antibody-based programme targeting autoimmune diseases.
Industrial talks | 24/03/2026 | By News Bureau | 117
194 Drug Samples Fail Quality Tests, CDSCO Flags 4 as Spurious in February Review
Central Drugs Standard Control Organisation has identified 194 drug samples as “Not of Standard Quality” (NSQ) during its routine monthly surveillance for February 2026, while four additional samples have been flagged as spurious.
Industrial talks | 24/03/2026 | By Darshana | 411
Illumina, Labcorp Expand Partnership to Boost Access to Precision Oncology Testing
Illumina and Labcorp deepen collaboration to expand next-generation sequencing-based cancer testing, improve access to biomarker diagnostics, and accelerate development of precision oncology solutions.
Industrial talks | 19/03/2026 | By News Bureau | 196
NIPER Raebareli Signs MoU with Roche Pharma India to Boost Pharma Education and Research
NIPER Raebareli partners with Roche Pharma India to launch regulatory training, industry lectures and AI-driven research initiatives, strengthening academia-industry collaboration in India’s pharmaceutical sector.
Industrial talks | 18/03/2026 | By News Bureau | 117
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy